New Postmarket Reporting Forms Detailed in Draft Guidance
The FDA has developed two new documents that it wants drug sponsors to use for annual postmarket reporting and is requesting comments on them in a new draft guidance.
Source: Drug GMP Report
The FDA has developed two new documents that it wants drug sponsors to use for annual postmarket reporting and is requesting comments on them in a new draft guidance.
Source: Drug GMP Report